Atopaxar

Atopaxar

SCHEMBL30008036

Br.CCOc1cc2c(c(F)c1OCC)C(=N)N(CC(=O)c1cc(N3CCOCC3)c(OC)c(C(C)(C)C)c1)C2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

F2R

The experimentally established mechanism targets of Atopaxar. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
F2R known ✓ P25116 16/20 1.00
MEN1 O00255 2/20 0.36
ALDH1A1 P00352 2/20 0.36
KMT2A Q03164 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 1/20 0.36
POLB P06746 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Atopaxar SCHEMBL1728925 1.00 F2R (1.00) F2RMEN1ALDH1A1KMT2AL3MBTL1
Atopaxar SCHEMBL29904776 1.00 F2R (1.00) F2RMEN1ALDH1A1KMT2AL3MBTL1
Atopaxar SCHEMBL30175034 0.99 F2R (1.00) F2RMEN1ALDH1A1KMT2AL3MBTL1
Atopaxar SCHEMBL1730339 0.99 F2R (1.00) F2RMEN1ALDH1A1KMT2AL3MBTL1
Atopaxar SCHEMBL1729065 0.98 F2R (0.98) F2RMEN1ALDH1A1KMT2AL3MBTL1
Bromide SCHEMBL1729548 0.96 F2R (0.93) F2RMEN1ALDH1A1KMT2AL3MBTL1
Bromide SCHEMBL1730058 0.94 F2R (0.88) F2RMEN1ALDH1A1KMT2AL3MBTL1
Bromide SCHEMBL1730235 0.93 F2R (0.87) F2RGAAMAPTSMN1; SMN2
SCHEMBL14449152 0.93 F2R (0.87) F2RGAAMAPTSMN1; SMN2
Bromide SCHEMBL5493294 0.92 F2R (0.85) F2RMEN1ALDH1A1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110393718-B Application and research method of atropa Sha Xiusuan as novel JAK-STAT3 signal pathway inhibitor 青岛海洋生物医药研究院 2022-10-04 CN disclosed